Clinical Trial

Trial Protocol ID AIS-D04_RUBY-4

Trial Description

A Phase 1b, Open-Label Study to Assess the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Povetacicept in Subjects with Autoimmune Cytopenias (RUBY-4)

View on ClinicalTrials.gov

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724

Investigator

  • Mohit Narang, MD

Sponsor

  • Alpine Immune Sciences, Inc.

ClinicalTrials.gov NCT ID

  • NCT05757570